Table 1.
Preoperative variables.
| Total (n = 11) |
TF-TAVI (n = 5) |
TA/TAO-TAVI (n = 6) |
|
|---|---|---|---|
| Male gender (n) | 7 (64%) | 2 (40%) | 5 (83%) |
| Age (years) | 79 (64–85) | 78 (76–79) | 83 (64–85) |
| EuroSCORE II | 7.8 (1.8–35.3) | 3.5 (1.8–7.8) | 10.9 (7.2–35.3) |
| Previous cerebral insult (n) | 2 (18%) | 1 (20%) | 1 (17%) |
| Coronary artery disease (n) | 10 (91%) | 5 (100%) | 5 (83%) |
| Previous coronary stenting (n) | 10 (91%) | 5 (100%) | 5 (83%) |
| Previous cardiac surgery (n) | 0 | 0 | 0 |
| Obstructive lung disease (n) | 6 (55%) | 1 (20%) | 5 (83%) |
| Dialysis (n) | 4 (36%) | 1 (20%) | 3 (50%) |
| Peripheral artery disease (n) | 7 (64%) | 2 (40%) | 5 (83%) |
| Implant size (mm) | 26 (23–34) | 26 (23–34) | 27.5 (23–34) |
TF-TAVI: transfemoral transcatheter aortic valve implantation, TA/TAO-TAVI: transapical/transaortal transcatheter aortic valve implantation.